Pharma’s partner for phase Ib of RCC trial
Merck partners with HiberCell for Phase Ib renal carcinoma trial
The Phase Ib trial will evaluate the ...
Author Archive
Malcolm Packer
Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.
Watch ‘What is SABR..’ Webinar
Resilience Over Adversity: The Mental Toll of VHL
Living with a rare disease can be challenging enough, especially when it impacts you physically. But for those ...
Medical Alert Card now available
We are pleased to offer these Medical Alert Card free of charge to kidney cancer patients which may be of help in ...
What Is SABR – Webinar
We are delighted to invite you to our next Living With Kidney Cancer Webinar on Tuesday 28th November at 6pm on ...
Charlie Peschardt’s Blog
This is a blog from Charlie Peschardt
Charlie is a veteran of the Royal Navy’s Commando helicopter force, was ...
Highest risk patients with RCC benefit from adjuvant everolimus
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell ...
Dovitinib Companion Diagnostic Shows Results in RCC
The drug response predictor companion diagnostic for dovinitib (DRP-Dovitinib) demonstrates potential to identify ...
Clinical Trial News – PEAR-TREE 2
Exploring how to match treatments to patients
Patients with advanced or metastatic kidney cancer now have a range ...
Kidney Cancer UK; Delivering Change for the patients
At the end of 2016, Kidney Cancer UK formed a multidisciplinary committee to look into the quality of services ...
A Second opinion; a second chance
Grab a cuppa, sit down and please take a few minutes read this blog about a second chance; I so hope this message ...
NICE recruiting committee members for kidney cancer guideline
The National Institute for Health and Care Excellence (NICE) is recruiting members for the committee that will ...
No results found.